Todd M. DuChene, serving as the Chief Legal and Administrative Officer at Core Scientific, Inc. (CORZ), executed a sale of the company's common stock on June 22, 2026. The transaction involved the disposal of 10,000 shares, resulting in proceeds of approximately $292,939. The sales were carried out under the parameters of a Rule 10b5-1 trading plan, which DuChene established on December 5, 2025.
The filing details two distinct transactions. In the initial sale, 7,600 shares were disposed of at a weighted average price of $29.1103. These shares were sold across multiple executions with prices varying between $28.61 and $29.58. The subsequent transaction involved the sale of 2,400 shares at a weighted average price of $29.8754, with prices ranging from $29.64 to $30.32.
Post-transaction, DuChene's direct ownership in Core Scientific stands at 2,048,895 shares. The insider sale follows a substantial period of appreciation for CORZ shares, which have generated a 139% return over the past year. However, data from InvestingPro indicates that the stock may currently be overvalued, trading above its established Fair Value. Investors are advised to note that CORZ exhibits extreme volatility, characterized by a beta of 5.48, a key insight from the comprehensive Pro Research Report.
Core Scientific has recently been the subject of several analyst reports and corporate developments. BTIG raised its price target for Core Scientific to $33, maintaining a Buy rating. This adjustment followed the company's addition of approximately 1.2 gigawatts of approved power capacity, including a new 430-megawatt site in Hunt County, Texas. Lucid Capital Markets initiated coverage on Core Scientific with a Buy rating and a price target of $40, emphasizing the company's position as the first Bitcoin-to-HPC converter and its strategic lease with CRWV. Freedom Broker also initiated coverage with a Hold rating and a price target of $33, noting its potential as a high-density colocation host for AI data center capacity.
In corporate governance news, Core Scientific appointed Steve Smith to its board of directors, where he will also serve on the Nominating and Corporate Governance Committee. Smith brings over 35 years of experience and is currently the CEO of Zayo Group. Additionally, Core Scientific held its 2026 Annual Meeting of Stockholders, where five individuals were elected to the board to serve until the 2027 meeting. These developments highlight ongoing strategic and operational moves within Core Scientific.